ProteinSimple MFI 5000 Series
4 December 2015 | By ProteinSimple
Address the US FDA requirement to characterize and quantify protein aggregates and other particle contaminants sized 1-70 microns in biotherapeutics...
List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
4 December 2015 | By ProteinSimple
Address the US FDA requirement to characterize and quantify protein aggregates and other particle contaminants sized 1-70 microns in biotherapeutics...
3 December 2015 | By ProteinSimple
Simple Western™ system that can separate, analyse and quantify proteins based on either size or charge…
Progress in the understanding of disease mechanisms provides new opportunities to discover molecules that modulate disease. To capitalise on these opportunities, successful lead discovery strategies need to build on insights into how a cellular phenotype or a target contributes to disease biology. Recent advances in induced pluripotent stem cells (iPSCs),…
2 December 2015 | By ProteinSimple
Simple Western™ system for the characterization of post-translational protein modification by the detection of charge isoforms...
20 November 2015 | By Victoria White
The compound exchange represents a novel, open innovation model of collaboration between the two companies.
15 October 2015 | By Charles River
Ligand-gated ion channels including, GABAA, NMDA, and nicotinic acetylcholine receptors, are important therapeutic targets in neurological disorders...
In this application note, learn how the manual MFI 5000 performs accurate particle analysis for viscous protein therapeutics, offering size, count and morphology...
Rapid analysis, platform methods and easy method development make the iCE3 ideal for analyzing biologics...
13 October 2015 | By Victoria White
Researchers have developed the first animal-free screening platforms capable of predicting the toxic effects of compounds on the human kidney accurately...
Due to protein therapeutic complexity, techniques like isoelectric focusing have become indispensable tools in evaluating biologic preparations...
Micro-Flow Imaging™ (MFI™) has new MVSS 4.0 software to classify particles across many biopharmaceutical samples easily and instantaneously...
In collaboration with Takeda, Micro-Flow Imaging with the Bot1 Autosampler automated manual methods for monitoring biopharmaceutical quality/safety...
Wes™ builds on over a decade of Simple Western development and makes running a Western even more simple...
Wes now analyzes proteins up to 440 kDa with the same Simple Western speed and data quality you’ve come to enjoy...
8 October 2015 | By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...